New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...
Hailed for opening a new chapter in food allergy management, oral immunotherapy (OIT) is nevertheless going through growing pains in accessibility and acceptance in clinical practice. In 2020, the FDA ...
File Photo/DAILY. Buy this photo. A Michigan Medicine study published Nov. 14, 2025 concluded transepidermal water loss — a measurement of the skin barrier’s permeability based on the amount of water ...
Researchers uncover why children with asthma or multiple allergies face higher odds of reacting during oral food challenges, and how better screening can make testing safer. Study: Asthma and ...
Food allergies are common and are associated with substantial morbidity; the only approved treatment is oral immunotherapy for peanut allergy. In this trial, we assessed whether omalizumab, a ...
New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma inhalers, are not associated with more severe reactions during oral food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results